Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel

An active surveillance programme was initiated by the Israeli Ministry of Health to ascertain the possible causal relationship between the vaccine and myocarditis and evaluate incidence, clinical relevance and related outcomes.

Read the full article here

Related Articles